Ovation Life Sciences
Latest round
- Series B
Last raised
- Dec 2020
Total raised
- $28M
Investors
- 6
About Ovation Life Sciences
Founded in 2009 in Cambridge, US, Ovation Life Sciences specializes in genomic and omics data linked to clinical data. The company has undergone significant developments, including a merger with PD Theranostics, Inc. in August 2024, enhancing its data offerings. The founding team includes Barry Wark, Jason Painter, and Winston Brasor, while Barry Wark serves as CEO.io specializes in generating high-value genomic and omics data intricately linked to extensive longitudinal clinical data. Key products include the Ovation Research Network, which mobilizes remnant samples for human health research, and Ovation LIMS, a laboratory information management system for molecular diagnostic laboratories. Their datasets, particularly on inflammatory bowel disease, offer comprehensive multiomics data, including whole genome and RNA sequencing, paired with curated clinical information to enhance biomarker discovery and patient stratification.io generates revenue through subscription models and partnerships within the life sciences sector. Clients access proprietary datasets and laboratory management solutions via annual contracts or project-based agreements. For example, subscriptions to the Ovation Research Network allow clients to utilize specific multiomics datasets for tailored research.In August 2024, Ovation Life Sciences, LLC merged with PD Theranostics, Inc., a move aimed at producing a comprehensive database of linked omics and clinical data for various diseases. The merger is expected to enhance their capabilities in data integration and research support. Future plans include the development of new products and expansion into additional geographic markets, though specific details on upcoming product launches or targeted regions have not been disclosed.50 mn will support these growth initiatives, further advancing their mission in the life sciences sector.
Who invested in Ovation Life Sciences
6 investors across 3 rounds
See all investors in Ovation Life Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ovation Life Sciences
Who invested in Ovation Life Sciences?
Ovation Life Sciences has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ovation Life Sciences raised?
Ovation Life Sciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ovation Life Sciences last raise money?
Ovation Life Sciences's most recent round on record is a Series B, in Dec 2020.
What does Ovation Life Sciences do?
Founded in 2009 in Cambridge, US, Ovation Life Sciences specializes in genomic and omics data linked to clinical data.
Where is Ovation Life Sciences headquartered?
Ovation Life Sciences is headquartered in Cambridge, US.
Which VCs invest in companies like Ovation Life Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Ovation Life Sciences's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Ovation Life Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.